Recall Atlas
Drugs & medicalClass II

Amerisource Health Services LLC recalls buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only,…

Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

Read the official notice →
Date
2024-07-17
Country
United States
Brand
Amerisource Health Services
Product
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by:…
Classification
Class II
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Amerisource Health Services recalls

  1. 2025-01-01
  2. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited,…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
  3. 2024-12-11
  4. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited,…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

    FDA · DrugAmerisource Health Services LLCPA, OH, PROfficial notice →
  5. 2024-08-07
  6. US
    Drugs & medicalClass I

    Amerisource Health Services LLC recalls Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, a).100-count bottle ( NDC 68001-396-00), b) 500-count…

    Failed Dissolution Specifications

    FDA · DrugAmerisource Health Services LLCUS Nationwide.Official notice →
  7. 2024-02-14
  8. US
    Drugs & medicalClass III

    Amerisource Health Services LLC recalls HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health…

    Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
  9. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio…

    CGMP Deviations

    FDA · DrugAmerisource Health Services LLCUSA NationwideOfficial notice →
  10. 2024-02-07
  11. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging,…

    Failed Impurities/Degradation Specification.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
All 31 Amerisource Health Services recalls →

Other drugs & medical recalls in the United States

  1. 2024-07-17
  2. US
    Drugs & medicalClass II

    TAILSTORM HEALTH INC recalls Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by…

    Subpotent Drug: reduced efficacy for epinephrine

    FDA · DrugTAILSTORM HEALTH INCNationwide in the USAOfficial notice →
  3. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC:…

    Cross contamination with other products.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
  4. US
    Drugs & medicalClass II

    Equibal Inc recalls Blemfree All Day Lotion (salicylic acid 0.5% w/w), packaged in a) 1 oz. 29 ML tube NDC:53228-003-01 b) 4 OZ 118ML plastic bottle, UPC 7…

    CGMP Deviations: Manufactured without following Current Good Manufacturing Practises.

    FDA · DrugEquibal IncNationwide in the USA via internet sales.Official notice →
  5. US
    Drugs & medicalClass II

    SYNCHRONICITY SPA INC, DBA SUNTE recalls suntegrity, (Zinc Oxide 15%) IMPECCABLE SKIN sunscreen foundation, Multiple Shades, Broad Spectrum SPF30, Net WT 2OZ (56.7 g),…

    CGMP Deviations

    FDA · DrugSYNCHRONICITY SPA INC, DBA SUNTEDistributed Nationwide in the USA and Queensland, Christchurch, Ontario,…Official notice →
  6. US
    Drugs & medicalClass I

    SYNCHRONICITY SPA INC, DBA SUNTE recalls suntegrity, (Zinc Oxide 15%) IMPECCABLE SKIN sunscreen foundation, BUFF, Broad Spectrum SPF30, Net WT 2OZ (56.7 g), Suntegrity…

    Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)

    FDA · DrugSYNCHRONICITY SPA INC, DBA SUNTEDistributed Nationwide in the USA and Queensland, Christchurch, Ontario,…Official notice →
  7. US
    Drugs & medicalClass II

    Baxter Healthcare Corporation recalls Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, For Intraperitoneal Administration Only, 6000 mL…

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.

    FDA · DrugBaxter Healthcare CorporationUS Nationwide, CanadaOfficial notice →
See all drugs & medical recalls →